Autonomix Medical Inc. Co... (AMIX)
NASDAQ: AMIX
· Real-Time Price · USD
1.10
-0.03 (-2.65%)
At close: Aug 18, 2025, 3:59 PM
1.10
0.00%
After-hours: Aug 18, 2025, 07:00 PM EDT
Autonomix Medical Common Stock Income Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 43K | 89K | 124K | 124K | 81K | 35K | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -43K | -89K | -124K | -124K | -81K | -35K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -11.59M | -10.75M | -10.93M | -9.36M | -7.47M | -5.71M | -3.33M | -2.47M | -1.99M | -1.33M | -788K | -394K |
Interest Income | 354K | 327K | 270K | 217K | 128K | 48K | 25K | 6K | n/a | n/a | n/a | n/a |
Pretax Income | -11.41M | -13.63M | -14.03M | -17.26M | -15.43M | -10.68M | -8.11M | -2.46M | -1.99M | -1.33M | -788K | -394K |
Net Income | -11.41M | -13.63M | -14.03M | -17.26M | -15.43M | -10.68M | -8.11M | -2.46M | -1.99M | -1.33M | -788K | -394K |
Selling & General & Admin | 6.86M | 6.74M | 7.27M | 6.29M | 4.99M | 3.75M | 1.86M | 1.51M | 1.33M | 995.22K | 650.22K | 325.11K |
Research & Development | 4.72M | 4.01M | 3.57M | 2.79M | 2.2M | 1.68M | 1.28M | 955.32K | 656.41K | 337.19K | 138.19K | 69.09K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 11.59M | 10.71M | 10.85M | 9.28M | 7.39M | 5.68M | 3.34M | 2.47M | 1.99M | 1.33M | 788.4K | 394.2K |
Interest Expense | 175K | 175K | 163K | 120K | 79K | 33K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | 1.3M | 1.3M | 1.13M | 1.22M | -84.75K | -84.75K | 88.25K | n/a | n/a | n/a |
Cost & Expenses | 11.59M | 10.75M | 10.93M | 11.56M | 9.68M | 7.92M | 5.54M | 2.47M | 1.99M | 1.33M | 788.4K | 394.2K |
Income Tax Expense | n/a | n/a | n/a | -2.38M | -2.38M | -2.38M | -2.38M | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.77M | 1.85M | 1.14M | 18.9M | 18.85M | 18.79M | 13.33M | 18.85M | 18.79M | 21.12M | 12M | 599K |
Shares Outstanding (Diluted) | 1.77M | 1.85M | 1.14M | 18.9M | 18.85M | 18.79M | 13.33M | 18.85M | 18.79M | 21.12M | 12M | 599.95K |
EPS (Basic) | -5.88 | -4.36 | -3.07 | -6.32 | -6.23 | -5.97 | -5.83 | -0.14 | -0.76 | -0.72 | -0.69 | -0.66 |
EPS (Diluted) | -5.88 | -4.36 | -3.07 | -6.32 | -6.23 | -5.97 | -5.83 | -0.14 | -0.76 | -0.72 | -0.69 | -0.66 |
EBITDA | -11.05M | -13.27M | -13.7M | -13.36M | -11.61M | -6.29M | -3.79M | -1.41M | -544K | -544K | n/a | n/a |
EBIT | -11.23M | -13.45M | -13.86M | -12.36M | -10.57M | -5.87M | -3.33M | -2.07M | -1.59M | -938K | -394K | -394K |
Depreciation & Amortization | 183K | 181K | 169K | 1.19M | 2.02M | 2.63M | 3.14M | 2.47M | 1.99M | 1.33M | 788.4K | 394.2K |